Stockscreener 앱 받기
5.79
1.36%
-0.08
전일 마감가:
$5.87
열려 있는:
$5.69
하루 거래량:
21,117
Relative Volume:
0.49
시가총액:
$805.69M
수익:
$9.96M
순이익/손실:
$-199.33M
주가수익비율:
-1.7374
EPS:
-3.3326
순현금흐름:
$-93.38M
1주 성능:
+2.12%
1개월 성능:
-6.46%
6개월 성능:
+96.94%
1년 성능:
+210.46%
1일 변동 폭
$5.5903
$5.8928
1주일 범위
$5.52
$6.18
52주 변동 폭
$1.60
$6.4999
인벤티바 Stock (IVA) Company Profile
IVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
5.79 | 816.28M | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
인벤티바 Stock (IVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 재개 | H.C. Wainwright | Buy |
| 2025-08-27 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | TD Cowen | Buy |
| 2024-11-12 | 개시 | UBS | Neutral |
| 2023-10-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-19 | 업그레이드 | Societe Generale | Sell → Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2022-11-15 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2021-03-08 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2020-08-05 | 개시 | ROTH Capital | Buy |
| 2020-08-04 | 개시 | Guggenheim | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
인벤티바 주식(IVA)의 최신 뉴스
Inventiva Appoints Andrew Obenshain as Chief Executive Officer - GlobeNewswire Inc.
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva SA Reports Progress and Challenges in 2025 - TipRanks
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva (NASDAQ:IVA) Shares Gap UpHere's What Happened - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $14.83 Average Target Price from Analysts - Defense World
Inventiva (NASDAQ:IVA) Shares Gap DownTime to Sell? - MarketBeat
Brokerages Set Inventiva S.A. Sponsored ADR (NASDAQ:IVA) PT at $14.83 - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Growth in Short Interest - MarketBeat
Inventiva (IVA) to Release Quarterly Earnings on Thursday - Defense World
Inventiva (NASDAQ:IVA) Shares Gap Down – Should You Sell? - Defense World
Brokers Set Expectations for Inventiva FY2025 Earnings - MarketBeat
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Increases By 188.0% - MarketBeat
Inventiva (NASDAQ:IVA) Shares Gap Up After Analyst Upgrade - MarketBeat
Inventiva (NASDAQ:IVA) Sees Large Volume Increase Following Analyst Upgrade - MarketBeat
Inventiva (NASDAQ:IVA) Earns Buy Rating from Analysts at HC Wainwright - Defense World
HC Wainwright Forecasts Inventiva FY2025 Earnings - Defense World
American Outdoor Brands Posts Downbeat Results, Joins Lululemon, Quanex Building And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva (NASDAQ:IVA) Price Target Raised to $13.00 at Guggenheim - Defense World
Why Did Inventiva Stock Plunge 10.82%? - AInvest
Inventiva (NASDAQ:IVA) Shares Gap Down – Here’s What Happened - Defense World
Inventiva (NASDAQ:IVA) Trading Up 4.3%Should You Buy? - MarketBeat
Inventiva (NASDAQ:IVA) Earns Overweight Rating from Analysts at Piper Sandler - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $10.40 Average Price Target from Brokerages - Defense World
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79% - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Inventiva (NASDAQ:IVA) Trading 4.3% Higher – What’s Next? - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Shares in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) - Defense World
Rokmaster Resources (CVE:RKR) Stock Price Up 71.4% – Still a Buy? - Defense World
Portofino Resources (CVE:POR) Trading Up 100% – Should You Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Stock Price Up 25% – Time to Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Shares Up 25% – Here’s Why - Defense World
Portofino Resources (CVE:POR) Stock Price Up 100% – Time to Buy? - Defense World
Honey Badger Silver (CVE:TUF) Trading Down 12% – Here’s What Happened - Defense World
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Here’s Why - Defense World
Inventiva (NASDAQ:IVA) Trading 2.7% Higher – Here’s Why - Defense World
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Inventiva sets share repurchase program terms post-meeting - Investing.com
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks
Stifel maintains Buy on Inventiva shares with $17 target - Investing.com
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks
Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com
인벤티바 (IVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):